ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

논문 상세

Home > 논문 상세
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

The Effect of Taglisodog-eum Extract on Lipopolysaccharide-induced Otitis media

대한한의학회지 / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2009, v.30 no.3, pp.51-60
정아름누리 (동국대학교)
홍승욱 (동국대학교)
  • 다운로드 수
  • 조회수

Abstract

Objectives:It has been known that immune reaction plays an important role in the pathogenesis of otitis media (OM). We investigated the change of middle ear mucosal inflammation induced by lipopolysaccharide (LPS) following administration of Taglisodog-eum (TSE) in experimental animals. Materials and Methods:Otitis media was induced by injecting 1 mg/kg of Pseudomonas aeruginosa LPS transtympanically in 60 rats. These rats were divided into two groups, the LPS group (n=30, remained naive after OM elicitation) and the TSE group (n=30, treated with TSE after OM elicitation) and 6 additional rats were kept as a normal control group (n=6, remained naive until tissue collection). The rats were killed at the 1st, 3rd, and 7th days after challenge. The temporal bones in each group were harvested and examined histopathologically by hematoxyline-eosin stain. Middle ear mucosa were taken at the 1st, 3rd, and 7th days after challenge. The levels of spicing variants of TNF-α transcription were evaluated by Realtime-PCR. Results:TSE suppressed LPS-induced TNF-α mRNA expression and thickness of the submucosal layer and infiltration of inflammatory cells in rat middle ear epithelium. Conclusion:The results suggest that TSE may be effective in decreasing inflammation with particular application to mucosal metaplasia in OM.

keywords
Otitis media with Effusion, Endotoxin, Taglisodog-eum (TSE)


참고문헌

1

Barrett TQ, Kristiansen LH, Ovesen T. NFkappa B in cultivated middle ear epithelium. Int J Pediatr Otorhinolaryngol, 2003;67(8):895-903.

2

Daly KA. Epidemiology of otitis media. Otolaryngol Clin North Am, 1991;24(4):775-86.

3

Richard M, Rosenfeld LC, Karen JD, Kenneth MG, Alejandro H, Margaret AK, et al. Clinical practice guideline: Otitis media with effusion. Otolaryngology-Head and Neck Surgery, 2004;130(5):95-118.

4

Tos M, BP. The pathogenesis of chronic secretory otitis media. Arch Otolaryngol Head Neck Surg, 1972;95:511-21.

5

Maeda K. Cytokine expression in experi- mental chronic otitis media with effusion in mice. Laryngoscope, 2004;114(11):1967-72.

6

Ovesen T, Ledet T. Bacteria and endotoxin in middle ear fluid and the course of secretory otitis media. Clin Otolaryngol Allied Sci, 1992;17(6):531-4.

7

Jung MK. Role of Inflammatory Mediators in the Pathogenesis of Otitis Media. Korean J Otolaryngol, 2007;50(1):2-13.

8

Kim JH, Kim HD, Bae SH, Lee JK, Kim CG, Na AS, et al. Studies on Relationships between Inflammatory Cell, Cytokines and Clinical Features in Pediatric Otitis Media with Effusion. Korean J Otolaryngol, 2003;46(10):815-21.

9

Lee EM, Park EJ. Otitis Media is one of the Most Common Disease of Otolaryngology and Pediatrics. J Korean Oriental Pediatrics, 1999;13(2):149-70.

10

Jo SH, Lee SG. A Clinical Report for Treatment 2 Cases on Takrisodokyeum of Otitis media. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology, 2002;15(1):301-7.

11

Jo SH, Lim JH, Lee SG, Jee SY. Case of Otitis Media Treated with Sonbanghwalmyongum. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology, 2003;16(1):198-205.

12

Kim HH, Park EJ, Joo JC. Effect of Kamihyunggyeyungyotang on Interleukin-8 & TGF-β in Middle Ear Effusion for Pediatric Recurrent Otitis Media with Effusion. J Korean Oriental Pediatrics, 2002;16(2):39-49.

13

Hwang-bo M, Lim JH, Jee SY, Lee SK. A Clinical Report for 2 Cases on Hyenggaeyeonggyotanghab- bojungikgitang of Otitis Media. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology, 2004;17(3):146-52.

14

Lee HJ, Park EJ. A Clinical Study on the Herbal Medicine Therapy Treating Pediatric Chronic Sinusitis and Otitis Media. J Korean Oriental Pediatrics, 1999;13(1):205-26.

15

Kim GS, Kim DG, Lee JY. An Experimental Syudy on the Anti-allergic effect on the Taklisodok- um. J Korean Oriental Pediatrics, 1994;8(1):27-37.

16

Seo HS. The effect of GamiTakliSodocyum on Wound Healing. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology, 2001;14(2):89-111.

17

Kang HG, Kim YH, Kang HS, Kim HD, Ko WS. The Anti-Inflammatory Effect of Takrisodokeum in the Ing-Juh. J Korean Oriental Med 2000;21(1):45-52.

18

Lee HJ. Apoptosis-inducing Effect of Taklisodokyeum Extract in Androgen Independent Prostate Cancer Cells. Graduate School of Wonkwang University, 2003.

19

Choi W. The effect of TaklisodokSan extract on anti-tumor action and immune-function. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology, 1999;12(1):79-98.

20

Kim MH, Lee JY, Lee JW, Cho CS, Kim CS. The Clinical Study in 20 Cases of Patients with Chronic Prostatitis on the effects by Taklisodokeum for 1 month. Daejon University, 2002;11(1):103-10.

21

Skotnicka B, Hassmann E. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol, 2000;257(6):323-6.

22

Hotomi M, Samukawa T, Yamanaka N. Interleukin- 8 in otitis media with effusion. Acta Otolaryngol, 1994;114(4):406-9.

23

Johnson MD. Cytokines in experimental otitis media with effusion. Laryngoscope, 1994;104(2):191-6.

24

Jeon EJ, Park YS, Choi Y, Lee JH. Effect of Inhibitor of TNF-α on Lipopolysaccharide-induced Otitis Media with Effusion. Korean J Otolaryngol, 2000;43:1040-4.

25

Albiin N. Middle ear mucosa in rats and humans. Ann Otol Rhinol Laryngol Suppl, 1986;126:2-15.

26

Park SN. The Effects of Antibiotics and Steroid on the Middle Ear Mucosa in the Rats with Experimental Acute Otitis Media. Korean J Otolaryngol, 2000;43(3):249-55.

27

Rhee CK. Effect of Platelet-Activating Factor and PAF-Antagonist on the Mucociliary Clearance of the Eustachian Tube in Guinea Pigs. Korean J Otolaryngol, 1999;42:273-8.

28

Lee DH, Choi YC, Jeon EJ, Yeo SW. Effect of Tumor Necrosis Factor-α on Experimental Otitis Media with Effusion. Korean J Otolaryngol, 2000;43(9):918-94.

29

Kim BG, Jung DG, Park SY, Yeo SW, Chae SY. Experimental Otitis Media with Effusion Induced by Interleukin 2. Korean J Otolaryngol, 2001;42(21-5).

30

DeMaria TF, Murwin DM. Tumor necrosis factor during experimental lipopolysaccharide- induced otitis media. Laryngoscope, 1997;107(3):369-72.

31

Ball SS. Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions. Ann Otol Rhinol Laryngol, 1997;106(8):633-9.

32

Iino Y, Kaneko Y, Takasaka T. Endotoxin in middle ear effusions tested with Limulus assay. Acta Otolaryngol, 1985;100(1-2):42-50.

33

Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest, 1987;56(3):234-48.

34

Pennica D. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature, 1984;312(5996):724-9.

35

Maxwell KS. Interleukin-8 expression in otitis media. Laryngoscope, 1994;104(8 Pt 1): 989-95.

36

Brodsky L. Arachidonic acid metabolites in middle ear effusions of children. Ann Otol Rhinol Laryngol, 1991;100(7):589-92.

37

Moon SK. Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzaeinduced up-regulation of human beta-defensin 2 in middle ear epithelial cells. BMC Infect Dis,2006;6:12.

상단으로 이동

대한한의학회지